Latin-American Consensus Conference on Helicobacter pylori infection

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Gastroenterology

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1572-0241.2000.03174.xPMID 11051336
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estimates of the worldwide incidence of 25 major cancers in 1990

  1999cited by this paper
• Helicobacter pylori in South America.

  1998cited by this paper
• Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio.

  1998cited by this paper
• Association between subjects with dyspeptic sumptoms and Helicobacter pylori infection: Epidemilogic study conducted at 16 centers in Argentina

  1998cited by this paper
• Second International Workshop on Helicobacter pylori Infections in the Developing World

  1997cited by this paper
• Seroprevalence of Helicobacter pylori infection in children of low socioeconomic level in Belo Horizonte, Brazil.

  1994cited by this paper
• The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age.

  1994cited by this paper
• NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.

  1994cited by this paper
• Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission.

  1993cited by this paper
• Transglutaminase in response to hypertonic NaCl-induced gastric mucosal injury in rats.

  1993cited by this paper
• Seroepidemiology of Campylobacter pylori infection in various populations

  1989cited by this paper

• Trends in the burden and quality of care for upper gastrointestinal diseases from 1990 to 2021: An analysis of the global burden of disease study 2021.

  2026cites this paper
• Non‐Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis

  2026cites this paper
• A Novel Pilot Program to Improve H. pylori Screening and Treatment in the US Immigrant and Refugee Population.

  2025cites this paper
• Caracterización clínica, histológica y endoscópica del cáncer gástrico en el Hospital de Especialidades Dr. Abel Gilbert Pontón, Ecuador

  2021cites this paper
• Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials

  2021cites this paper
• Histopathological Spectrum of Upper Gastrointestinal Endoscopic Biopsies in a Tertiary care centre

  2021cites this paper
• Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance

  2019cites this paper
• Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori

  2019cites this paper
• Validated HPLC Determination of the Potential Anti-Helicobacter pylori, Lepidine, in Lepidium sativum Seeds Assessed by Molecular Docking Study

  2019cites this paper
• Five alternative Helicobacter pylori antibiotics to counter high levofloxacin and metronidazole resistance in the Dominican Republic

  2019cites this paper
• An optimized clarithromycin-free 14-day triple therapy for Helicobacter pylori eradication achieves high cure rates in Uruguay.

  2017cites this paper
• Infection by Helicobacter pylori in Nova Iguaçu City, Rio de Janeiro Province, Brazil

  2017cites this paper
• Seroprevalence of Helicobacter pylori in Hispanics living in Puerto Rico: A population‐based study

  2017cites this paper
• Helicobacter pylori recurrence after eradication in Latin America: Implications for gastric cancer prevention

  2017cites this paper
• Cancer mortality predictions for 2017 in Latin America

  2017cites this paper
• Cancer patterns and trends in Central and South America.

  2016cites this paper
• Eradication of Helicobacter Pylori Infection: Past, Present and Future

  2016cites this paper
• "HELICOBACTER PYLORI, HOY". UNA HISTORIA DE 30 AÑOS… "HELICOBACTER PYLORI, TODAY" A 30 YEAR'S HISTORY…

  2016cites this paper
• Stomach cancer burden in Central and South America.

  2016cites this paper
• Etiology of non-Hodgkin lymphoma ( C 82 – 85 , C 96 ) in Central and South America

  2016cites this paper
• Etiology of stomach cancer ( C 16 ) in Central and South America

  2016cites this paper
• A Randomised Trial of empiric 14-day Triple, five-day Concomitant, and ten-day Sequential Therapies for Helicobacter pylori in Seven Latin American Sites

  2016cites this paper
• Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial

  2016cites this paper
• Terapia clásica frente a terapia secuencial en la erradicación de la infección por Helicobacter pylori

  2016cites this paper
• Prevalence of Helicobacter pylori resistance to clarithromycin determined by 23S ribosomal RNA analysis in Jordan. Diab AF1, Diab FH2, Nassar SS3. Faculty of Medicine, University of Jordan1; Departments of Medicine2 and Laboratory Medicine3, Khaldi Medica

  2016cites this paper
• Association between Helicobacter pylori and intestinal parasites in an Añu indigenous community of Venezuela

  2016cites this paper
• Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection.

  2015cites this paper
• [How do gastroenterologists in Peru deal with Helicobacter pylori infection? Study based on a survey conducted in 2014].

  2015cites this paper
• Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta‐analysis

  2015cites this paper
• Avaliação das células T CD8+ em gastrite associada ou não à infecção pela bactéria Helicobacter pylori

  2015cites this paper
• “HELICOBACTER PYLORI, HOY”. UNA HISTORIA DE 30 AÑOS…

  2015cites this paper
• Clinical Management of Helicobacter pylori: The Latin American Perspective

  2014cites this paper
• Furazolidone-Based Quadruple Therapy for Eradication of Helicobacter pylori Infection in Peptic Ulcer Disease

  2014cites this paper
• Second and third line treatment options for Helicobacter pylori eradication.

  2014cites this paper
• Helicobacter pylori — Current Therapy and Future Therapeutic Strategies

  2014influential citation
• The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America

  2014cites this paper
• Biopsia de tubo digestivo alto

  2014cites this paper
• Exploring alternative treatments for Helicobacter pylori infection.

  2014cites this paper
• Helicobacter Pylori Treatment with Alternative Drugs: Good and Cheap for Developing Countries Furazolidone-Based Treatment- Omeprazole, Furazolidone and Tetracycline Open-Label Trial in A Developing Country: Why Not?

  2014cites this paper
• Trends in mortality from major cancers in the Americas: 1980-2010.

  2014cites this paper
• Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.

  2014cites this paper
• Hematologic manifestations of Helicobacter pylori infection.

  2014cites this paper
• Evolución de la respuesta al tratamiento de primera línea de la infección por Helicobacter pylori en Uruguay

  2014cites this paper
• Lipopolysaccharide structure of Helicobacter pylori serogroup O:3.

  2013cites this paper
• Prueba de aliento con urea marcada con carbono 13 para el diagnóstico de Helicobacter pylori

  2013influential citation
• Evaluación de la utilidad de diferentes métodos para el diagnóstico de Helicobacter pylori Evaluation of the usefulness of different methods for diagnosis of Helicobacter pylori

  2013cites this paper
• Current recommendations for Helicobacter pylori therapies in a world of evolving resistance

  2013cites this paper
• Helicobacter pylori infection

  2013cites this paper
• 3rd Brazilian Consensus on Helicobacter pylori.

  2013cites this paper
• Clinical Outcomes of Two‐Week Sequential and Concomitant Therapies for Helicobacter pylori Eradication: A Randomized Pilot Study

  2013cites this paper
• Furazolidone-based Therapies for Helicobacter pylori Infection: A Pooled-data Analysis

  2012cites this paper
• Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations

  2012cites this paper
• Prevalence of upper digestive endoscopy and gastric histopathology findings in morbidly obese patients.

  2012cites this paper
• Helicobacter pylori Eradication Therapy: Current Availabilities

  2012cites this paper
• Basis for the Management of Drug-Resistant Helicobacter pylori Infection

  2012cites this paper
• Scientific section: LYMPHOID NEOPLASIA Title: Classification of Non-Hodgkin Lymphoma in Central and South America: a Review of 1028 Cases Authors:

  2012cites this paper
• Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.

  2012cites this paper
• Prevalence of self-reported chronic diseases in individuals over the age of 40 in São Paulo, Brazil: the PLATINO study.

  2012cites this paper
• Randomized study of seven days of standard treatment for Helicobacter Pylori vs. ten days of standard treatment for Helicobacter Pylori with one year follow-ups of patients

  2012cites this paper
• A Comparison between Sequential Therapy and a Modified Bismuth‐based Quadruple Therapy for Helicobacter pylori Eradication in Iran: A Randomized Clinical Trial

  2012cites this paper
• Pantoprazole

  2012cites this paper
• Risk factors for gastric cancer in Latin America: a meta-analysis

  2012cites this paper
• 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.

  2011cites this paper
• Relationship between cagA-positive Helicobacter pylori infection and risk of gastric cancer: a case control study in Porto Alegre, RS, Brazil.

  2011cites this paper
• Lipopolysaccharide structures of Helicobacter pylori wild-type strain 26695 and 26695 HP0826::Kan mutant devoid of the O-chain polysaccharide component.

  2011cites this paper
• Pruebas de aliento basadas en sustratos marcados con carbono 13 Breath test based on substrates labeled with carbon 13

  2011influential citation
• Review article: non‐bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori

  2011cites this paper
• Estudo prospectivo da mucosa do coto gástrico em pacientes submetidos a gastrectomia subtotal distral para Carcinoma gástrico

  2010cites this paper
• Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.

  2010cites this paper
• Sequential Therapy for Helicobacter pylori Eradication: A Critical Review

  2010cites this paper
• The prevalence of Helicobacter pylori infection in patients undergoing upper gastrointestinal endoscopy in the Turks and Caicos Islands.

  2010cites this paper
• Endoscopy in treatment of non-complicated dyspepsia: truths and shadows.

  2009cites this paper
• Caracterización endoscópica e histológica de Caracterización endoscópica e histológica de Caracterización endoscópica e histológica de Caracterización endoscópica e histológica de Caracterización endoscópica e histológica de

  2009cites this paper
• Helicobacter pylori: algunos aspectos epidemiológicos en Latinoamérica luego de un cuarto de siglo

  2009cites this paper
• Helicobacter pylori infection.

  2009cites this paper
• Prevalence of H. Pylori infection in patients with Gastroduodenal diseasein Pakistan

  2008cites this paper
• Antibiotics resistance of Helicobacter pylori at the San Ignacio University Hospital in Bogota

  2008cites this paper
• Helicobacter pylori and the endoscopic and histological lesions in the gastric mucosa of patients aged 50 and over

  2008cites this paper
• Analysis of Helicobacter pylori isolates from Chile: occurrence of selective type 1 Lewis b antigen expression in lipopolysaccharide.

  2008cites this paper
• Dyspepsia: clinical aspects and current approach

  2008cites this paper
• Dispepsia: caracterização e abordagem

  2008cites this paper
• Resistencia antibiótica del Helicobacter pylori en el Hospital Universitario San Ignacio de Bogotá Antibiotics resistance of Helicobacter pylori at the San Ignacio University Hospital in Bogota

  2008cites this paper
• Short-term triple therapy with azithromycin for Helicobacter pylori eradication: Low cost, high compliance, but low efficacy

  2008cites this paper
• Grandes síndromes gastrointestinales (2): dispepsia o síndrome del aparato digestivo alto relacionado con alimentos (2)

  2008cites this paper
• Treatment of Helicobacter pylori infection. A survey in a group of generalists medical and specialists in Colombia

  2007cites this paper
• Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile.

  2007cites this paper
• Nitrofuran‐based regimens for the eradication of Helicobacter pylori infection

  2007cites this paper
• Susceptibility Profile to Common Antimicrobials Used for Eradication of Helicobacter pylori Infection in Mexico by Agar Dilution Method

  2007cites this paper
• Helicobacter pylori and antibiotic resistance

  2007cites this paper
• Treatment of H. pylori infection: Current recommendations

  2007cites this paper
• Tratamiento de la infección por Helicobacter pylori. Encuesta en un grupo de médicos generales y especialistas en Colombia

  2007cites this paper
• Avaliação endoscópica da doença do refluxo gastroesofágico e relação com infecção pelo Helicobacter pylori

  2007cites this paper
• Can Helicobacter pylori Eradication Regimens be Shortened in Clinical Practice? An Open-label, Randomized, Pilot Study of 4 and 7-day Triple Therapy With Rabeprazole, High-dose Levofloxacin, and Tinidazole

  2006cites this paper
• ‘Rescue’ Therapies for the Management of Helicobacter pylori Infection

  2006cites this paper
• Evaluation of the efficacy of triple therapy regimen for Helicobacter pylori eradication in gastrectomized patients with gastric adenocarcinoma

  2006cites this paper
• Third-line rescue therapy for Helicobacter pylori infection.

  2006cites this paper
• Antibiotic therapy for Helicobacter pylori.

  2006cites this paper
• Helicobacter pylori y cáncer gástrico

  2006cites this paper
• A 10‐day levofloxacin‐based triple therapy in patients who have failed two eradication courses

  2005cites this paper
• New once‐daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study

  2005cites this paper